Literature DB >> 29210939

VASCULAR REMODELING OF CHOROIDAL NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VISUALIZED ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Alexandra Miere1, Pauline Butori1, Salomon Y Cohen1,2, Oudy Semoun1, Vittorio Capuano1, Camille Jung2, Eric H Souied1,2.   

Abstract

PURPOSE: To describe the qualitative and quantitative changes in choroidal neovascularization (CNV) flow pattern after anti-vascular endothelial growth factor therapy, by optical coherence tomography angiography (OCTA).
METHODS: Consecutive patients with neovascular age-related macular degeneration underwent multimodal imaging, including OCTA at initial examination and at last visit. High-flow networks in the choriocapillaris segmentation of OCTA were qualitatively and quantitatively analyzed at baseline and at follow-up, to characterize vascular flow changes after anti-vascular endothelial growth factor treatment and to correlate these changes with final exudation signs on spectral domain optical coherence tomography.
RESULTS: Seventeen eyes were included. Mean follow-up was of 11.7 ± 3.3 months. Baseline images showed six medusa pattern (35.3%), four seafan pattern (23.5%), and seven indistinct network patterns (41.2%). Mean CNV area at baseline was 1.58 ± 1.72 mm. Final OCTA images revealed a decrease in CNV total area of 21.6%. In 6/17 eyes, the baseline neovascular pattern was unchanged; these cases were associated with exudation at the final spectral domain optical coherence tomography examination (P = 0.034) and a decrease in CNV area of 34.1%. Conversely, in 11/17 eyes (64.7%), the initial pattern had changed to a pruned vascular tree pattern, with variable exudative status on spectral domain optical coherence tomography at the final visit and a decrease in total CNV area of 0.07%.
CONCLUSION: The vascular flow remodeling induced by recurrent anti-vascular endothelial growth factor treatment can be assessed by OCTA. Optical coherence tomography angiography may help to accurately evaluate treatment response and to recognize patterns usually associated with recurrent exudative activity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29210939     DOI: 10.1097/IAE.0000000000001964

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  17 in total

1.  Nonexudative morphologic changes of neovascularization on optical coherence tomography angiography as predictive factors for exudative recurrence in age-related macular degeneration.

Authors:  Han Joo Cho; Jaemin Kim; Seung Kwan Nah; Jihyun Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-13       Impact factor: 3.117

2.  Quantitative analysis of branching neovascular networks in polypoidal choroidal vasculopathy by optical coherence tomography angiography after photodynamic therapy and anti-vascular endothelial growth factor combination therapy.

Authors:  Wen-Yi Wang; Chang-Hao Yang; Ta-Ching Chen; Yi-Ting Hsieh; Tzyy-Chang Ho; Chung-May Yang; Fang-Yu Liu; Tso-Ting Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-08       Impact factor: 3.117

3.  Effect of total anti-VEGF treatment exposure on patterns of choroidal neovascularisation assessed by optical coherence tomography angiography in age-related macular degeneration: a retrospective case series.

Authors:  Livia Faes; Zaria Ali; Siegfried Wagner; Praveen J Patel; Dun Jack Fu; Lucas M Bachmann; Martin K Schmid; Nadia Waheed; Pearse A Keane; Konstantinos Balaskas
Journal:  BMJ Open Ophthalmol       Date:  2019-04-09

4.  Optical coherence tomography angiography features of choroidal neovascularization secondary to angioid streaks.

Authors:  T Chapron; G Mimoun; A Miere; M Srour; A El Ameen; O Semoun; E H Souied
Journal:  Eye (Lond)       Date:  2018-09-24       Impact factor: 3.775

5.  One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial.

Authors:  Fenghua Wang; Yuanzhi Yuan; Ling Wang; Xiaofeng Ye; Jingke Zhao; Mengxi Shen; Qi Zhang; Ding Xu; Guoyou Qin; Wei Zhang; Fei Yuan; Qing Chang; Peiquan Zhao; Fang Wang; Xiaodong Sun
Journal:  J Ophthalmol       Date:  2019-10-10       Impact factor: 1.909

6.  Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography.

Authors:  Kunho Bae; Hyo Jung Kim; Yong Kyun Shin; Se Woong Kang
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

7.  Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission.

Authors:  Florence Coscas; Diogo Cabral; Telmo Pereira; Carlos Geraldes; Hemaxi Narotamo; Alexandra Miere; Marco Lupidi; Alexandre Sellam; Ana Papoila; Gabriel Coscas; Eric Souied
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

Review 8.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12

9.  Optic Coherence Tomography Angiography Findings of Bilateral Choroidal Neovascularization Associated with Optic Disc Drusen Treated with Intravitreal Aflibercept Injection.

Authors:  Melih Akıdan; Mehmet Bulut; Lütfiye Yaprak; Muhammet Kazım Erol; Elcin Suren
Journal:  Case Rep Ophthalmol Med       Date:  2020-03-10

10.  Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography.

Authors:  Lu-Na Cheng; Yu-Xi Lin; Lei Liu; Xu-He Zhang; Yan-Qi Xue; Sheng-Di Zhou; Zhe-Li Liu; Han Zhang
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.